EMERYVILLE, Calif., May 6, 2011 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE Amex:NBY) presented a poster at the 2011 Conference of the Association for Research in Vision and Ophthalmology (ARVO) held this week in Fort Lauderdale, Florida. The poster was prepared by researchers from NovaBay Pharmaceuticals and Kathryn Najafi, MD, Ophthalmologist of Eye Institute of Marin in San Rafael, California and titled "Aganocide® Compounds Effective Against Ophthalmic Pathogens."
